Conditional Survival After Surgical Treatment of Melanoma: An Analysis of the Surveillance, Epidemiology, and End Results Database
Annals of Surgical OncologyPublished 17 February 2010
Natasha M. Rueth, Shawn S. Groth, Todd M. Tuttle, Beth A Virnig, Waddah B. Al‐Refaie, Elizabeth B. Habermann
Citations37
SJR quartileQ1
SJR score1.15
SNIP1.09
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
For patients who survive 8 years after surgical treatment of melanoma, CS data become discordant with traditionally used estimates, and have important implications for patient counseling, as high-risk melanoma survivors may require no more intensive surveillance than low-risk survivors 8 years after treatment.
Abstract
For patients who survive 8 years after surgical treatment of melanoma, CS data become discordant with traditionally used estimates. Our findings have important implications for patient counseling, as high-risk melanoma survivors may require no more intensive surveillance than low-risk survivors 8 years after treatment.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Archives of SurgeryTechnical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
4,383 Citations1992Donald L. Morton
Patients with early stage melanoma who have nodal metastases and are likely to benefit from radical lymphadenectomy are identified, with a high degree of accuracy, by a new procedure developed using vital dyes.
Journal of Clinical OncologyInterferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
2,104 Citations1996J M Kirkwood, M H Strawderman +4 more
IFN alpha-2b is the first agent to show a significant benefit in relapse-free and overall survival of high-risk melanoma patients in a randomized controlled trial.
New England Journal of MedicineSentinel-Node Biopsy or Nodal Observation in Melanoma
1,808 Citations2006Donald L. Morton, John F. Thompson +12 more
The staging of intermediate-thickness primary melanomas according to the results of sentinel-node biopsy provides important prognostic information and identifies patients with nodal metastases whose survival can be prolonged by immediate lymphadenectomy.
Annals of Surgical OncologyLong-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
481 Citations2000Charles M. Balch, Seng‐Jaw Soong +10 more
Long-term survival rates from patients treated at 77 institutions demonstrate that ulceration and tumor thickness are dominant predictive factors that should be used in the staging of stages I and II melanomas, and confer a survival advantage for these subgroups of prospectively defined melanoma patients.
CA A Cancer Journal for CliniciansAn Evidence-based Staging System for Cutaneous Melanoma
389 Citations2004Charles M. Balch, Seng-Jaw Soong +16 more
A completely revised staging system for cutaneous melanoma was implemented in 2003 and a new convention was implemented for defining clinical and pathological staging so as to take into account the new staging information gained from lymphatic mapping and sentinel node biopsy.
Annals of SurgeryLymphatic Drainage of Skin to a Sentinel Lymph Node in a Feline Model
279 Citations1991Jan H. Wong, Leslie A. Cagle +1 more
The predictable pattern of drainage of the skin in this feline model supports the feasibility of selective lymphadenectomy and proves to a useful model to examine the utility of mapping dyes and to demonstrate dermal lymphatics.
CancerAge and gender are significant independent predictors of survival in primary cutaneous melanoma
247 Citations2008Konstantinos Lasithiotakis, Ulrike Leiter +6 more
The aim was to identify age‐ related and gender‐related differences in the clinical presentation and outcome of patients with primary cutaneous melanoma.
Journal of Surgical OncologyLessons learned from the Sunbelt Melanoma Trial
233 Citations2004Kelly M. McMasters, R. Dirk Noyes +7 more
A practical definition of sentinel nodes based on the degree of radioactivity is developed and the low rate of postoperative complications associated with SLN biopsy as compared to complete lymph node dissection is established, suggesting that completion lymphadenectomy is appropriate for such patients.
Annals of Surgical OncologyCorrelation Between Prognostic Factors and Increasing Age in Melanoma
219 Citations2004Celia Chao, Robert C.G. Martin +7 more
As age increases, so does Breslow thickness, the incidence of ulceration and regression, and the proportion of male patients—all poor prognostic factors; however, the frequency of SLN metastasis declines with increasing age, and this represents a decreased sensitivity of the SLN procedure in older patients.
Journal of Clinical OncologyConditional Survival of Patients With the Four Major Histologic Subgroups of Lung Cancer in Denmark
170 Citations2003Halla Skúladóttir, Jørgen H. Olsen
For patients who have survived more than 1 year, the conditional survival probability provides a more accurate estimate of survival as compared with the conventional observed survival rates.
PubMedLong-term cancer patient survival in the United States.
166 Citations1998Phyllis A. Wingo, Lynn A. G. Ries +2 more
Annals of Surgical OncologyComplete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States
136 Citations2008Karl Y. Bilimoria, Charles M. Balch +6 more
Only half of patients with sentinel node-positive melanoma underwent CLND, and patients treated at NCCN/NCI-designated centers were significantly more likely to undergo nodal evaluation in concordance with established guidelines.
PubMedOptimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.
132 Citations2003Philip I. Haigh, L. Andrew DiFronzo +1 more
Surgical excision margins no more than 2 cm around a melanoma of the trunk or extremities are adequate; overall survival, disease-free survival and recurrence rate are not adversely affected compared with a wider excision.
CHEST JournalConditional Survival Among Patients With Carcinoma of the Lung
116 Citations1999Ray M Merrill, Donald E. Henson +1 more
One- and 5-year prognosis for lung cancer patients is influenced by years already survived and histology, stage, and age at diagnosis, and annual hazards and conditional survival provides useful and more relevant information than conventional survival estimates for patients and their physicians.
Gynecologic OncologyConditional survival in ovarian cancer: Results from the SEER dataset 1988–2001
114 Citations2008Mehee Choi, Clifton D. Fuller +2 more
Prognosis improves over time for almost all groups of ovarian cancer patients, and conditional survival provides a more relevant measure of prognosis than conventional survival estimates made at the time of diagnosis.
Annals of OncologyPrognosis for long-term survivors of cancer
102 Citations2007M.L.G. Janssen‐Heijnen, Saskia Houterman +4 more
Prognosis for patients with cancer generally improved with each year survived, whereas for Patients with other tumours survival remained poorer than for the general population.
Cancer ControlMelanoma in Hispanic and Black Americans
96 Citations2008Panta Rouhani, Shasa Hu +1 more
More comprehensive medical training, expanded public educational campaigns, and increased awareness among patients of all skin types to perform self skin checks are recommended.
CancerConditional survival estimates improve over time for patients with advanced melanoma
87 Citations2010Yan Xing, George J. Chang +8 more
The objective of this analysis was to provide melanoma‐specific CS estimates to help clinicians promote more informed patient decision making.
CancerConditional median survival of patients with advanced carcinoma
85 Citations2001Ikuko Kato, Richard K. Severson +1 more
There are no published data on the conditional median survival of patients with advanced carcinoma on a population basis, but there are calls for further research into this issue.
Journal of Clinical OncologyPopulation-Based Assessment of Surgical Treatment Trends for Patients With Melanoma in the Era of Sentinel Lymph Node Biopsy
84 Citations2005Janice N. Cormier, Yan Xing +6 more
Although treatment trends are improving, SLN biopsy continues to be underused, particularly in the elderly and minority populations, in patients with truncal and head/neck melanomas, and also in some geographic regions of the United States.
CancerImproved survival time: What can survival cure models tell us about population‐based survival improvements in late‐stage colorectal, ovarian, and testicular cancer?
73 Citations2008Lan Huang, Kathleen A. Cronin +3 more
The objective of the current study was to investigate the long‐term impact of treatment advances on the survival of patients with late‐stage ovarian, colorectal, and testicular cancers by estimating the increase in the percentage cured from their disease and the change in survival time of uncured patients.
CancerThe annual risk of melanoma progression. Implications for the concept of cure
71 Citations1992Craig L. Slingluff, Richard K. Dodge +2 more
This poster focuses on the treatment of patients with locally advanced or distant metastatic melanoma with or without a prior history of central giant cell granuloma, which has a high potential for recurrence.
Annals of Surgical OncologyThe Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2–pT3)
64 Citations2008Zbigniew Nowecki, Piotr Rutkowski +1 more
The results of the study demonstrate that the survival benefit after positive sentinel node biopsy with subsequent CLND is probably limited only to the subgroup of patients with primary tumor thicknesses not larger than 4 mm and not less than 1 mm when compared with lymph node dissection of palpable nodes.
Annals of Surgical OncologyAdverse Outcomes Associated with Noncompliance with Melanoma Treatment Guidelines
58 Citations2008Jennifer E. Foster, Josè M. Velasco +1 more
While there are valid reasons for variance from treatment algorithms, data suggest that compliance with NCCN guidelines improves outcome and decreases morbidity in clinically node-negative melanoma patients.
CancerLymph node ratio predicts disease‐specific survival in melanoma patients
58 Citations2009Yan Xing, Brian D. Badgwell +6 more
The objectives of this analysis were to compare various measures associated with lymph node (LN) dissection and to identify threshold values associated with disease‐specific survival (DSS) outcomes in patients with melanoma.
CancerThe long‐term clinical course of patients with cutaneous melanoma
39 Citations2002John W. Gamel, Stephen L. George +2 more
A parametric survival model was used that incorporated a cured fraction of patients to translate pathologic and clinical factors into specific estimates of long‐term outcome of cutaneous melanoma.
Annals of Surgical OncologyRegional Nodal Metastatic Disease Is the Strongest Predictor of Survival in Patients with Thin Vertical Growth Phase Melanomas: A Case for SLN Staging Biopsy in These Patients
34 Citations2007Giorgos C. Karakousis, Phyllis A. Gimotty +7 more
RNMD was the most statistically significant factor associated with MRD in patients with thin VGP lesions, and supports the prognostic use of SLN biopsy in this group, recognizing that additional factors, including thickness, axial location, and older age were independently associated with a worse survival outcome.